Literature DB >> 25168130

Primary cutaneous mucormycosis in a patient with burn wounds due to Lichtheimia ramosa.

Ravinder Kaur1, Kiran Bala, Rajeev B Ahuja, Prabhat Srivastav, Umesh Bansal.   

Abstract

Mucormycosis is usually an invasive mycotic disease caused by fungi in the class mucormycetes. Here we report a case of cutaneous mucormycosis due to Lichtheimia ramosa in a 20-year-old female patient with burn injuries. She was admitted to the hospital with accidental flame burns covering 60 % total burn surface area. After 15 days of admission to hospital, the burn wound showed features of fungal infection. Culture showed white cottony growth belonging to the Mucorales order. Morphological identification confirmed it as L. ramosa. She was managed surgically and medically with the help of amphotericin B. Patient survived due to prompt diagnosis and appropriate medical and surgical treatment. Early diagnosis is critical in prevention of morbidity and mortality associated with the disease. Fungal infection in burn wounds can be difficult to diagnose and manage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25168130     DOI: 10.1007/s11046-014-9805-x

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  34 in total

Review 1.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Primary cutaneous zygomycosis from a tertiary care centre in north-west India.

Authors:  J Chander; J Kaur; A Attri; H Mohan
Journal:  Indian J Med Res       Date:  2010-06       Impact factor: 2.375

Review 3.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

4.  Topical nystatin powder in severe burns: a new treatment for angioinvasive fungal infections refractory to other topical and systemic agents.

Authors:  J P Barret; P I Ramzy; J P Heggers; C Villareal; D N Herndon; M H Desai
Journal:  Burns       Date:  1999-09       Impact factor: 2.744

5.  Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases.

Authors:  Jan Däbritz; Andishe Attarbaschi; Kathrin Tintelnot; Nina Kollmar; Bernhard Kremens; Friederike D von Loewenich; Lothar Schrod; Friedhelm Schuster; Uwe Wintergerst; Michael Weig; Thomas Lehrnbecher; Andreas H Groll
Journal:  Mycoses       Date:  2011-05-30       Impact factor: 4.377

Review 6.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 7.  Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient.

Authors:  F Mattner; H Weissbrodt; M Strueber
Journal:  Scand J Infect Dis       Date:  2004

8.  Fungal burn wound infection. A 10-year experience.

Authors:  W K Becker; W G Cioffi; A T McManus; S H Kim; W F McManus; A D Mason; B A Pruitt
Journal:  Arch Surg       Date:  1991-01

9.  Mucormycosis as a rare cause of severe gastrointestinal bleeding after multivisceral transplantation.

Authors:  S Irtan; M Lamerain; F Lesage; V Verkarre; M-E Bougnoux; F Lanternier; J R Zahar; N Salvi; C Talbotec; O Lortholary; F Lacaille; C Chardot
Journal:  Transpl Infect Dis       Date:  2013-09-18       Impact factor: 2.228

10.  Three cases of cutaneous mucormycosis with Lichtheimia spp. (ex Absidia/Mycocladus) in ICU. Possible cross-transmission in an intensive care unit between 2 cases.

Authors:  P Poirier; C Nourrisson; L Gibold; E Chalus; D Guelon; S Descamp; O Traore; M Cambon; C Aumeran
Journal:  J Mycol Med       Date:  2013-10-18       Impact factor: 2.391

View more
  5 in total

1.  [Not Available].

Authors:  Jf Arnould; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

2.  The genome sequence of four isolates from the family Lichtheimiaceae.

Authors:  Marcus C Chibucos; Kizee A Etienne; Joshua Orvis; Hongkyu Lee; Sean Daugherty; Shawn R Lockhart; Ashraf S Ibrahim; Vincent M Bruno
Journal:  Pathog Dis       Date:  2015-04-09       Impact factor: 3.166

3.  Necrotizing fasciitis in neonate by Lichtheimia ramosa : A case study.

Authors:  Ashish William; Ravinder Kaur; Deepti Rawat; Neelam S S Kandir; Akanksha Sharma
Journal:  Access Microbiol       Date:  2022-03-09

4.  Case report: A rare case of pulmonary mucormycosis caused by Lichtheimia ramosa in pediatric acute lymphoblastic leukemia and review of Lichtheimia infections in leukemia.

Authors:  Guo-Qian He; Ling Xiao; Zhen Pan; Jian-Rong Wu; Dong-Ni Liang; Xia Guo; Ming-Yan Jiang; Ju Gao
Journal:  Front Oncol       Date:  2022-08-15       Impact factor: 5.738

5.  Cutaneous and Pulmonary Mucormycosis in Rag1- and Il2rg-deficient Rats.

Authors:  Anna E Sarfaty; Susan R Compton; Peter C Smith; Caroline J Zeiss
Journal:  Comp Med       Date:  2020-07-31       Impact factor: 0.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.